1 CE Course · 1 CE
Mood Disorders & Treatment-Resistant Depression (1 CE)
Neurobiology of mood disorders and treatment-resistant depression, current treatment limitations, emerging interventions, and ethical considerations in clinical research.
Course Overview
OPFM2: Mood Disorders & Treatment-Resistant Depression — A Research-Based Approach. Mental health disorders, particularly major depressive disorder (MDD) and treatment-resistant depression (TRD), are among the most pressing challenges in neuroscience and psychology. This course explores the neurobiological mechanisms underlying mood disorders, the limitations of current treatments, and emerging interventions that offer new hope for individuals facing TRD. By engaging with cutting-edge research, neuroimaging studies, and clinical trials, students gain a deep understanding of how novel therapies impact brain function, neuroplasticity, and emotional regulation. The course also examines the ethical and regulatory considerations that shape clinical investigations in this field.
Learning Objectives
- Examine the neurobiological mechanisms underlying mood disorders.
- Analyze research on alternative approaches to modulating brain function in cases of treatment-resistant depression (TRD).
- Identify ethical and regulatory considerations in clinical investigations related to mood disorders.
Course Outline
1. Understanding Mood Disorders & Treatment Challenges
- Overview of major depressive disorder (MDD) and treatment-resistant depression (TRD).
- Neurochemical imbalances, brain connectivity disruptions, and the role of the Default Mode Network (DMN).
- Current standard treatments (SSRIs, psychotherapy) and limitations in TRD cases.
2. Neurobiological Mechanisms of Mood Regulation
- Effects of novel interventions on serotonin receptors, neuroplasticity, and emotional processing.
- Brain imaging research on altered connectivity in depression.
- The role of neuroplasticity and synaptic rewiring in mood regulation.
3. Academic Findings on Emerging Interventions
- Review of randomized controlled trials (RCTs) exploring innovative approaches to mood disorders.
- Carhart-Harris et al. (2016, 2021) — Investigating novel interventions in TRD (New England Journal of Medicine).
- Summary of reported outcomes, efficacy, and methodological considerations.
4. Regulatory Considerations & Future Research
- Ethical considerations in novel treatment studies.
- Compliance with research ethics, informed consent, and safety protocols.
- Ongoing developments in neuroplasticity and mental health research.
Assessment & Certification
- Assessment
- 10-question multiple-choice test covering key neurobiological mechanisms and research findings.
- Certification
- Certificate of Completion automatically generated upon successful completion for 1 continuing education credit.
Referenced Research
- Carhart-Harris et al. (2016, 2021). Investigating novel interventions in treatment-resistant depression. New England Journal of Medicine.
Format & Delivery
Self-paced online course with reading materials, video lectures, and an end-of-course quiz.